Atypical antipsychotics and delirium in critical care
-
* Corresponding author: Matt P Wise mattwise@doctors.org.uk
Department of Critical Care, University Hospital of Wales, Cardiff CF14 4XW, UK
Critical Care 2011, 15:453 doi:10.1186/cc10493
See related research by Wanet al.,http://ccforum.com/content/15/3/R159
Published: 16 November 2011First paragraph (this article has no abstract)
Wan and colleagues recently reported a case series of patients with refractory delirium successfully treated with the atypical antipsychotic drug quetiapine. This class of medication is used infrequently by critical care physicians at present and offers a potentially useful treatment for a group of patients who are clinically challenging to manage. However, larger studies are required to evaluate both efficacy and adverse events in a critically ill population.